# P2Y12 inhibitors (drug class)

Drug · id `cardio:p2y12-inhibitors` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: P2Y12 Platelet Inhibitor; P2Y12 Receptor Antagonists

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

P2Y12 inhibitors are antiplatelet medicines that act on the P2Y12 receptor of platelets. The US labels of ticagrelor, clopidogrel and prasugrel, the three members recorded in this atlas so far, put each in this class. The labels say each medicine prevents platelet activation by acting on the platelet receptor: ticagrelor reversibly, and clopidogrel and prasugrel through the irreversible binding of an active metabolite. This is the class page: what each medicine has been shown to do sits on its own page.

## Technical summary

US drug-label classes in RxClass for ticagrelor: established pharmacologic class P2Y12 Platelet Inhibitor (EPC) and mechanism-of-action class P2Y12 Receptor Antagonists (MOA). No MeSH heading is recorded for the class, because none was looked up for it; the identifiers list is empty for that reason. The label writes the class name with a space (P2Y 12). Clopidogrel and prasugrel carry the same two RxClass classes in the labels read. The class names are recorded from the RxClass responses of 2026-10-30 (ticagrelor) and 2026-11-09 (clopidogrel, prasugrel).

## Connected pages

- Files under this front: Medicines (`cardio:front-medicines`)
- Related to: Antiplatelet drugs (`cardio:antiplatelet-drugs`)
- Has subtype: Clopidogrel (`cardio:clopidogrel`)
- Has subtype: Prasugrel (`cardio:prasugrel`)
- Has subtype: Ticagrelor (`cardio:ticagrelor`)

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 72 registry trials

## Provenance

Content hash: 511663dfa47f129ae08ae8af2ceecd96996467425b34b73db8e6661c2f8a6eba
Last substantive edit: 2026-11-09
Evidence last checked: 2026-10-30
